Is Spinal Muscular Atrophy Fatal?

Is Spinal Muscular Atrophy Fatal?

Spinal muscular atrophy can be fatal, particularly in the most severe forms that appear in infancy, but the disease exists on a broad spectrum where many individuals live well into adulthood with proper care and treatment.

How SMA Type Determines Outlook

The prognosis depends on which SMA type a person has, a classification system based on age of symptom onset and motor milestones achieved:

• Type 0 – Prenatal onset; very rare, often fatal in infancy.
• Type 1 (Werdnig-Hoffmann disease) – Symptoms appear by 6 months; historically fatal by age 2 without respiratory support, though interventions and newer therapies are extending survival.
• Type 2 – Onset between 6 and 18 months; individuals typically learn to sit but not walk, with variable life expectancy that can extend into adulthood.
• Type 3 (Kugelberg-Welander disease) – Onset after 18 months; normal or near-normal life expectancy, though mobility declines over time.
• Type 4 – Adult-onset; normal life expectancy with mild muscle weakness.

What Makes SMA Life-Threatening

The primary danger in severe SMA is respiratory failure. Because the muscles that control breathing and coughing weaken, individuals are vulnerable to pneumonia and other infections. Nutritional complications from swallowing difficulties can also affect survival.

How Treatment Is Changing Survival

Disease-modifying therapies such as nusinersen (Spinraza), onasemnogene abeparvovec (Zolgensma), and risdiplam (Evrysdi) have significantly altered the natural history of SMA. Early treatment, often before symptoms appear through newborn screening, is associated with better motor outcomes and improved survival, especially in Type 1.

Factors That Influence Longevity

Beyond the SMA type and treatment timing, several factors shape how long someone lives with the condition:

• Access to multidisciplinary care, including pulmonology and nutrition support
• Use of non-invasive ventilation and airway clearance techniques
• Timely management of scoliosis and respiratory infections
• Individual variation in SMN2 gene copy number

The Bottom Line

While SMA can be fatal, especially in its earliest and most severe forms, the landscape has shifted dramatically. With early diagnosis and modern therapies, many individuals with SMA now survive into adulthood, and ongoing research continues to improve long-term outcomes.